Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas
Status:
Completed
Trial end date:
2006-07-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing
so they stop growing or die. Combining more than one drug may kill more cancer cells.
PURPOSE: This phase I trial is studying the side effects and best dose of
carboxyamidotriazole and paclitaxel in treating patients with advanced solid tumors or
refractory lymphomas.
Phase:
Phase 1
Details
Lead Sponsor:
National Institutes of Health Clinical Center (CC)